Short‐Duration Pan‐Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection
暂无分享,去创建一个
G. Cooke | G. Dore | C. Orkin | K. Petoumenos | S. Bhagani | E. Gane | D. Shaw | J. Grebely | M. Nelson | M. Martinello | G. Matthews | R. Kulasegaram | E. Tu | P. Marks